998 related articles for article (PubMed ID: 25493025)
1. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH
World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025
[TBL] [Abstract][Full Text] [Related]
2. Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977-2011.
Trier Moller F; Andersen V; Andersson M; Jess T
Inflamm Bowel Dis; 2015 Dec; 21(12):2825-32. PubMed ID: 26288000
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
4. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
6. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
Annese V; Andreoli A; Andriulli A; Dinca R; Gionchetti P; Latiano A; Lombardi G; Piepoli A; Poulain D; Sendid B; Colombel JF
Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
[TBL] [Abstract][Full Text] [Related]
7. Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Disease.
Hwang SW; Kwak MS; Kim WS; Lee JM; Park SH; Lee HS; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH; Yang SK
J Crohns Colitis; 2016 Sep; 10(9):1024-32. PubMed ID: 26933029
[TBL] [Abstract][Full Text] [Related]
8. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
Saberzadeh-Ardestani B; Anushiravani A; Mansour-Ghanaei F; Fakheri H; Vahedi H; Sheikhesmaeili F; Yazdanbod A; Moosavy SH; Vosoghinia H; Maleki I; Nasseri-Moghaddam S; Khosravi B; Malekzadeh M; Kasaeian A; Alatab S; Sadeghi A; Kolahdoozan S; Rayatpisheh M; Sima AR; Malekzadeh R
Inflamm Bowel Dis; 2022 Jul; 28(7):1004-1011. PubMed ID: 34417824
[TBL] [Abstract][Full Text] [Related]
9. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting.
Trinder MW; Lawrance IC
J Gastroenterol Hepatol; 2009 Jul; 24(7):1252-7. PubMed ID: 19220669
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic concordance in familial inflammatory bowel disease (IBD). Results of a nationwide IBD Spanish database.
Cabré E; Mañosa M; García-Sánchez V; Gutiérrez A; Ricart E; Esteve M; Guardiola J; Aguas M; Merino O; Ponferrada A; Gisbert JP; Garcia-Planella E; Ceña G; Cabriada JL; Montoro M; Domènech E;
J Crohns Colitis; 2014 Jul; 8(7):654-61. PubMed ID: 24388046
[TBL] [Abstract][Full Text] [Related]
12. Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea.
Park SH; Kim YH; Lee JH; Kwon HJ; Lee SH; Park DI; Kim HK; Cheon JH; Im JP; Kim YS; Lee SY; Lee SJ
Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():35-44. PubMed ID: 26395533
[TBL] [Abstract][Full Text] [Related]
13. Disease severity in familial cases of IBD.
Andreu M; Márquez L; Domènech E; Gisbert JP; García V; Marín-Jiménez I; Peñalva M; Gomollón F; Calvet X; Merino O; Garcia-Planella E; Vázquez-Romero N; Esteve M; Nos P; Gutiérrez A; Vera I; Cabriada JL; Martín MD; Cañas-Ventura A; Panés J;
J Crohns Colitis; 2014 Mar; 8(3):234-9. PubMed ID: 24016462
[TBL] [Abstract][Full Text] [Related]
14. Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study.
Henriksen M; Jahnsen J; Lygren I; Vatn MH; Moum B;
Am J Gastroenterol; 2007 Sep; 102(9):1955-63. PubMed ID: 17573793
[TBL] [Abstract][Full Text] [Related]
15. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
16. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease--a population-based study.
Jakobsen C; Bartek J; Wewer V; Vind I; Munkholm P; Groen R; Paerregaard A
Aliment Pharmacol Ther; 2011 Nov; 34(10):1217-24. PubMed ID: 21981762
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne.
Prideaux L; Kamm MA; De Cruz P; Williams J; Bell SJ; Connell WR; Brown SJ; Lust M; Desmond PV; Chan H; Chow DK; Wu JC; Leong RW; Sung JJ; Chan FK; Ng SC
J Gastroenterol Hepatol; 2012 May; 27(5):919-27. PubMed ID: 22098103
[TBL] [Abstract][Full Text] [Related]
18. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
Vande Casteele N; Ferrante M; Van Assche G; Ballet V; Compernolle G; Van Steen K; Simoens S; Rutgeerts P; Gils A; Vermeire S
Gastroenterology; 2015 Jun; 148(7):1320-9.e3. PubMed ID: 25724455
[TBL] [Abstract][Full Text] [Related]
19. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
[TBL] [Abstract][Full Text] [Related]
20. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population.
Halme L; Turunen U; Heliö T; Paavola P; Walle T; Miettinen A; Järvinen H; Kontula K; Färkkilä M
Scand J Gastroenterol; 2002 Jun; 37(6):692-8. PubMed ID: 12126248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
